CCJ Total Non-Current Liabilities

Cameco Corporation Common Stock · Total Non-Current Liabilities

CCJ logo

CCJ Total Non-Current Liabilities

Latest reported$2.36B CAD
CCJ Quarterly Total Non-Current Liabilities · CAD ($201.80M → $2.36B)
High-resolution chart · PNG

CCJ total non-current liabilities history

Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cameco Corporation Common Stock Total Non-Current Liabilities — Quarterly (CAD)
Period endingTotal Non-Current Liabilities (CAD)
2,364,323,969
1,663,513,301
2,325,821,062
2,327,356,000
2,231,179,000
2,337,887,000
2,356,913,000
2,549,698,000
2,707,065,000
2,358,198,001
2,650,644,000
1,652,943,000
1,701,166,000
2,210,254,001
2,235,887,000
2,142,020,000
1,615,935,011
2,164,213,000
2,258,033,000
2,224,831,000
2,245,791,000
2,213,368,001
2,318,487,000
2,292,782,000
2,274,223,001
1,536,286,226
1,661,750,530
2,313,196,000
2,308,798,000
2,167,502,000
2,149,169,000
2,094,776,000
2,568,301,000
2,518,182,000
2,508,074,000
2,416,601,000
2,457,417,000
2,534,393,000
2,521,415,000
2,643,225,000
2,575,002,000
2,563,207,000
2,577,721,000
2,531,504,000
2,508,664,000
2,620,725,000
2,513,049,000
2,398,800,000
2,263,753,000
2,023,615,000
1,985,372,000
2,021,732,000
2,029,206,000
2,096,068,000
2,562,941,000
2,095,779,000
1,968,825,000
1,973,795,000
1,988,307,000
1,836,148,000
1,696,034,000
1,723,091,000
1,672,193,000
1,610,134,000
1,602,209,000
1,636,675,000
1,571,177,000
1,694,260,000
1,398,666,000
2,497,400,000
1,827,557,066
1,320,919,736
1,366,931,610
1,385,974,694
1,507,249,975
1,443,622,181
1,422,518,597
1,453,587,408
1,497,008,388
1,443,470,437
1,383,891,801
1,456,855,441
1,439,399,930
1,200,932,636
1,397,849,515
1,283,142,685
1,249,654,428
1,281,826,887
1,347,598,399
1,269,278,594
927,021,770
1,003,246,894
1,086,760,772
1,176,503,599
905,827,825
842,309,523
815,208,365
812,912,683
957,663,165
942,581,663
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.